Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 222

1.

Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.

de Almeida SM, Rotta I, Jiang Y, Li X, Raboni SM, Ribeiro CE, Smith D, Potter M, Vaida F, Letendre S, Ellis RJ; HNRC Group.

J Neurovirol. 2016 Jul 11. [Epub ahead of print]

PMID:
27400932
2.

The Veterans Aging Cohort Study (VACS) Index and Neurocognitive Change: A Longitudinal Study.

Marquine MJ, Montoya JL, Umlauf A, Fazeli PL, Gouaux B, Heaton RK, Ellis RJ, Letendre SL, Grant I, Moore DJ; HIV Neurobehavioral Research Program Group.

Clin Infect Dis. 2016 May 19. pii: ciw328. [Epub ahead of print]

PMID:
27199461
3.

Pill Burden Influences the Association Between Time-Based Prospective Memory and Antiretroviral Therapy Adherence in Younger But Not Older HIV-Infected Adults.

Sheppard DP, Weber E, Casaletto KB, Avci G, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Assoc Nurses AIDS Care. 2016 Apr 6. pii: S1055-3290(16)30022-X. doi: 10.1016/j.jana.2016.03.006. [Epub ahead of print]

PMID:
27160771
4.

Putamen volume and its clinical and neurological correlates in primary HIV infection.

Wright PW, Pyakurel A, Vaida FF, Price RW, Lee E, Peterson J, Fuchs D, Zetterberg H, Robertson KR, Walter R, Meyerhoff DJ, Spudich SS, Ances BM.

AIDS. 2016 Jul 17;30(11):1789-94. doi: 10.1097/QAD.0000000000001103.

PMID:
27045376
5.

Apolipoprotein E ε4 genotype status is not associated with neuroimaging outcomes in a large cohort of HIV+ individuals.

Cooley SA, Paul RH, Fennema-Notestine C, Morgan EE, Vaida F, Deng Q, Chen JA, Letendre S, Ellis R, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Ances BM; CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) Group.

J Neurovirol. 2016 Mar 28. [Epub ahead of print]

PMID:
27021072
6.

Microstructural changes to the brain of mice after methamphetamine exposure as identified with diffusion tensor imaging.

McKenna BS, Brown GG, Archibald S, Scadeng M, Bussell R, Kesby JP, Markou A, Soontornniyomkij V, Achim C, Semenova S; Translational Methamphetamine Aids Research Center Tmarc Group.

Psychiatry Res. 2016 Mar 30;249:27-37. doi: 10.1016/j.pscychresns.2016.02.009. Epub 2016 Feb 24.

PMID:
27000304
7.

Improved Method to Stratify Elderly Patients With Cancer at Risk for Competing Events.

Carmona R, Zakeri K, Green G, Hwang L, Gulaya S, Xu B, Verma R, Williamson CW, Triplett DP, Rose BS, Shen H, Vaida F, Murphy JD, Mell LK.

J Clin Oncol. 2016 Apr 10;34(11):1270-7. doi: 10.1200/JCO.2015.65.0739. Epub 2016 Feb 16.

PMID:
26884579
8.

The impact of age, HIV serostatus and seroconversion on methamphetamine use.

Montoya JL, Cattie J, Morgan E, Woods SP, Cherner M, Moore DJ, Atkinson JH, Grant I; Translational Methamphetamine Aids Research Center (TMARC) Group.

Am J Drug Alcohol Abuse. 2016 Mar;42(2):168-77. doi: 10.3109/00952990.2015.1114625. Epub 2016 Feb 2.

PMID:
26837461
9.

Health-Related Everyday Functioning in the Internet Age: HIV-Associated Neurocognitive Disorders Disrupt Online Pharmacy and Health Chart Navigation Skills.

Woods SP, Iudicello JE, Morgan EE, Cameron MV, Doyle KL, Smith TV, Cushman C; HIV Neurobehavioral Research Program (HNRP) Group.

Arch Clin Neuropsychol. 2016 Mar;31(2):176-85. doi: 10.1093/arclin/acv090. Epub 2016 Jan 6.

PMID:
26743327
10.

Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era.

Kallianpur AR, Wang Q, Jia P, Hulgan T, Zhao Z, Letendre SL, Ellis RJ, Heaton RK, Franklin DR, Barnholtz-Sloan J, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I; CHARTER Study Group.

J Infect Dis. 2016 Apr 1;213(7):1065-73. doi: 10.1093/infdis/jiv754. Epub 2015 Dec 21.

PMID:
26690344
11.

Physical Activity Affects Brain Integrity in HIV+ Individuals.

Ortega M, Baker LM, Vaida F, Paul R, Basco B, Ances BM.

J Int Neuropsychol Soc. 2015 Nov;21(10):880-9. doi: 10.1017/S1355617715000879.

12.

Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients.

Ma Q, Vaida F, Wong J, Sanders CA, Kao YT, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, Morgello S, Simpson DM, Heaton RK, Grant I, Letendre SL; CHARTER Group.

J Neurovirol. 2016 Apr;22(2):170-8. doi: 10.1007/s13365-015-0382-7. Epub 2015 Sep 25.

PMID:
26407716
13.

Does Older Age Confer an Increased Risk of Incident Neurocognitive Disorders Among Persons Living with HIV Disease?

Sheppard DP, Woods SP, Bondi MW, Gilbert PE, Massman PJ, Doyle KL; HIV Neurobehavioral Research Program Group.

Clin Neuropsychol. 2015;29(5):656-77. doi: 10.1080/13854046.2015.1077995. Epub 2015 Aug 26.

PMID:
26367342
14.

Continued Slow Decay of the Residual Plasma Viremia Level in HIV-1-Infected Adults Receiving Long-term Antiretroviral Therapy.

Riddler SA, Aga E, Bosch RJ, Bastow B, Bedison M, Vagratian D, Vaida F, Eron JJ, Gandhi RT, Mellors JW; ACTG A5276s Protocol Team.

J Infect Dis. 2016 Feb 15;213(4):556-60. doi: 10.1093/infdis/jiv433. Epub 2015 Sep 2.

PMID:
26333941
15.

Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection.

Hulgan T, Samuels DC, Bush W, Ellis RJ, Letendre SL, Heaton RK, Franklin DR, Straub P, Murdock DG, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, McCutchan JA, Morgello S, Simpson DM, Grant I, Kallianpur AR; CHARTER Group.

Clin Infect Dis. 2015 Nov 1;61(9):1476-84. doi: 10.1093/cid/civ527. Epub 2015 Jun 30.

PMID:
26129753
16.

Risk Factors for Bloodstream Infection After Living-donor Liver Transplantation in Children.

Shoji K, Funaki T, Kasahara M, Sakamoto S, Fukuda A, Vaida F, Ito K, Miyairi I, Saitoh A.

Pediatr Infect Dis J. 2015 Oct;34(10):1063-8. doi: 10.1097/INF.0000000000000811.

PMID:
26121201
17.

CSF biomarkers of monocyte activation and chemotaxis correlate with magnetic resonance spectroscopy metabolites during chronic HIV disease.

Anderson AM, Fennema-Notestine C, Umlauf A, Taylor MJ, Clifford DB, Marra CM, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Simpson DM, Morgello S, Grant I, Letendre SL; CHARTER Group.

J Neurovirol. 2015 Oct;21(5):559-67. doi: 10.1007/s13365-015-0359-6. Epub 2015 Jun 12.

PMID:
26069183
18.

Randomized trials of endoscopic therapy and transjugular intrahepatic portosystemic shunt versus portacaval shunt for emergency and elective treatment of bleeding gastric varices in cirrhosis.

Orloff MJ, Hye RJ, Wheeler HO, Isenberg JI, Haynes KS, Vaida F, Girard B, Orloff KJ.

Surgery. 2015 Jun;157(6):1028-45. doi: 10.1016/j.surg.2014.12.003.

PMID:
25957003
19.

Typologies of positive psychotic symptoms in methamphetamine dependence.

Bousman CA, McKetin R, Burns R, Woods SP, Morgan EE, Atkinson JH, Everall IP, Grant I; Translational Methamphetamine AIDS Research Center (TMARC) Group.

Am J Addict. 2015 Mar;24(2):94-7. doi: 10.1111/ajad.12160.

20.

Time estimation and production in HIV-associated neurocognitive disorders (HAND).

Doyle KL, Morgan EE, Weber E, Woods SP; HIV Neurobehavioral Research Program (HNRP) Group.

J Int Neuropsychol Soc. 2015 Feb;21(2):175-81. doi: 10.1017/S1355617715000089.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk